Evidence map›Paper›PMID 30941510›Full record

ArticleAnnals of hematology2019

Detection of AML-specific TP53 mutations in bone marrow-derived mesenchymal stromal cells cultured under hypoxia conditions.

Marian Müller, Ricarda Graf, Karl Kashofer, Susanne Macher, Albert Wölfler, Armin Zebisch, Andelko Hrzenjak, Ellen Heitzer, Heinz Sill

Open access · hybridAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of hematology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Germline mutations: many roles in leukemogenesis.Current opinion in hematology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Marian MüllerDivision of Hematology, Medical University of Graz, Auenbruggerplatz 38, A-8036, Graz, Austria.
Ricarda GrafInstitute of Human Genetics, Diagnostic and Research Center for Molecular Biomedicine, Medical University of Graz, Graz, Austria.
Karl KashoferInstitute of Pathology, Medical University of Graz, Graz, Austria.
Susanne MacherDepartment for Blood Group Serology and Transfusion Medicine, Medical University of Graz, Graz, Austria.
Albert WölflerDivision of Hematology, Medical University of Graz, Auenbruggerplatz 38, A-8036, Graz, Austria.
Armin ZebischDivision of Hematology, Medical University of Graz, Auenbruggerplatz 38, A-8036, Graz, Austria.
Andelko HrzenjakDivision of Pulmonology, Medical University of Graz, Graz, Austria.
Ellen HeitzerInstitute of Human Genetics, Diagnostic and Research Center for Molecular Biomedicine, Medical University of Graz, Graz, Austria.
Heinz SillDivision of Hematology, Medical University of Graz, Auenbruggerplatz 38, A-8036, Graz, Austria. heinz.sill@medunigraz.at.
Medical University of Graz · ATLudwig Boltzmann Institute for Lung Vascular Research · AT

Funding

Austrian Science Fund FWF P 31430
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genes, NeoplasmGenes, p53MutationBone MarrowCell DifferentiationCell HypoxiaDNA, NeoplasmHumansLeukemia, Myeloid, AcuteMesenchymal Stem CellsNeoplasm ProteinsNeoplastic Stem CellsOxygenPolymorphism, Single NucleotideTumor Cells, CulturedTumor MicroenvironmentDNA, NeoplasmNeoplasm ProteinsOxygenTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID30941510
PMCPMC6647597
OpenAlexW2933693039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.